摘要:
Remedies for polycystic ovary syndrome which contain as the active ingredient compounds represented by general formula (1) or (2) or pharmaceutically acceptable salts thereof, wherein each symbol is as defined in the description.
摘要:
Novel benzimidazole derivatives represented by general formula (I) or salts thereof, which have hypoglycemic and PDE5-inhibiting effects and are therefore useful as drugs; in formula (I) R1 is lower alkyl which may be substituted with lower alkyloxy; R2 is hydrogen, halogeno, C1-C8 alkyl, aryl, or the like; R3 is lower alkyl, lower alkenyl, aryl, lower alkylaryl, aryl-substituted lower alkenyl, halothienyl, lower alkylamino or aryl lower alkylamino; A is a benzene ring, a naphthalene ring, or a pyridine ring; and X is halogeno.
摘要:
Sulfonamide compounds represented by the general formula (I) R1-SO2NHCO-A-X-R2, salts thereof, and medicinal compositions containing the same. In said formula, R1 represents alkyl, alkenyl, alkynyl, etc.; A represents an optionally substituted polyheterocyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenz-imidazolyl and 2,3-dihydrobenzoxazinyl; X represents alkylene, oxygen, oxygenated lower alkylene, etc.; and R2 represents optionally substituted aryl, substituted biphenylyl, etc. These compounds are useful in treating diseases curable based on the hypoglycemic effect, and diseases curable based on the cGMP-PDE inhibitory, leiolytic, bronchodilating, vasodilating, smooth muscle cell inhibitory, and antiallergic effects.
摘要:
New benzimidazole derivatives of general formula (I) or salts thereof, useful as medicines, wherein R1 is alkyl or the like; R2 is aromatic ring-containing lower alkyl which may be substituted; R3 is alkyl or the like; and -X- is a group of general formula (V) or the like.
摘要:
Sulfonamide compounds represented by general formula (I), or salts thereof; and drug compositions containing the same (wherein each symbol is as defined in the description). These compounds serve as preventive or therapeutic agents efficacious against diseases which can be cured through decrease in blood sugar level and those which can be cured through inhibition of cGMP-PDE, relaxation of smooth muscle, bronchodilation, vasodilation, inhibition of smooth muscle fiber, or inhibition of allergy.
摘要:
3-(2,4-Dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3H-benzimidazole-5-carboxamide having a hypoglycemic activity or a PDE5 inhibitory effect occurs as three crystalline forms which are distinguishable from each other based on the powdery X-ray diffraction data. The most stable crystalline form thereof is useful as a bulk powder for drugs. Other crystalline forms comprise larger crystals, which can be very easily isolated by filtration and efficiently purified by crystallization, are useful in purifying 3-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-3H-benzimidazole-5-carboxamide.
摘要:
Novel indole derivatives represented by formula (I) or salts thereof, wherein R1 is aryl-substituted lower alkyl in which the aryl may be substituted by at least one member selected among halogen atoms, aryls, heterocyclic groups, aryl-substituted lower alkyls, aryl-substituted lower alkenyls, lower haloalkyls, (lower cycloalkyl)-substituted lower alkyloxys, (lower cycloalkyloxy)-substituted lower alkyls, aryl-substituted lower alkynyls, aryloxy-substituted lower alkyls, aryl-substituted lower alkyloxys, lower alkylthios, lower alkyloxys, and alkenyls; and R2 is a lower alkyl, lower alkenyl, aryl, or heterocyclic group optionally substituted by halogeno, lower alkyl, lower alkenyl, or aryl. These compounds have a hypoglycemic activity and a PDE5 inhibitory activity and are useful as a drug.
摘要:
Imidazole compounds represented by general formula (I) and salts thereof and medicinal compositions containing the same. These compounds are useful in treating diseases which can be treated based on the hypoglycemic effect thereof, and diseases which can be treated based on the cGMP-PDE inhibitory effect, smooth muscular relaxant effect, bronchodilating effect, vasodilating effect, smooth muscle cell regulatory effect and allergy-inhibitory effects thereof, wherein each symbol is as defined in the description.
摘要:
Novel aromatic ring derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof. Because of having hypoglycemic and PDE 5 inhibitory activities, these compounds and salts thereof are useful as remedies for impaired glucose tolerance, diabetes, complication of diabetes, insulin-resistant syndrome, polycystic ovary syndrome, hyperlipidemia, atherosclerosis, cardio-vascular diseases, hyperglycemia, hypertension, angina pectoris, pulmonary hypertension, congestive heart failure, glomerular diseases, tubular interstitial diseases, renal insufficiency, atherosclerosis, angiostenosis, peripheral vascular diseases, cerebral stroke, chronic reversible obstructive diseases, autoimmune diseases, allergic rhinitis, urticaria, glaucoma, diseases characterized by disordered intestinal motion, sexual impotence, nephritis, cachexia, pancreatitis, post-PTCA reconstriction, etc. In said formula (I), Nu represents a 5- or 6-membered aromatic ring; ch1 and ch2 represent each a cross-linking group; and A represents an aromatic ring.